PRESS RELEASE
News
-
-
-
-
PRESS RELEASE
Planting Hope Accelerates Foodservice Strategy and Profitability Drive with Two New Board Directors and Chief Financial Officer
The Planting Hope Company appoints two new board members and a CFO, grants stock options, and expands into the Chinese market with the appointment of Qing Meyerson, bringing extensive financial skills and Asian market operations know-how -
PRESS RELEASE
Skeena Provides Exploration Update and 2024 Outlook
Skeena Resources Limited announces 2023 drilling results from Eskay Creek Gold-Silver Project and outlook for 2024 exploration programs. High-grade mineralization discovered near mine and in Eskay Deeps, prompting seismic survey and regional exploration plans -
PRESS RELEASE
Nextech3D.ai Reports $5 Million in 2023 Revenue, Growth Up +56% Preliminary Unaudited Results
Nextech3D.AI (OTCQX:NEXCF)(CSE:NTAR)(FSE:1SS) announces preliminary unaudited financial and operating results for full year 2023, showing strong annual revenue growth of 56% to $5 million. CEO projects even stronger gains in 2024 with major AI technology and contracts for 3D modeling business -
-
PRESS RELEASE
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TUI AG issues notification of major holdings under Article 40, Section 1 of the WpHG [German Securities Trading Act] with the aim of Europe-wide distribution. The Goldman Sachs Group, Inc. has acquired/disposed shares and instruments, resulting in a change of breakdown of voting rights -
PRESS RELEASE
Custodian Property Income REIT plc: Directors’ purchase of ordinary shares
Custodian Property Income REIT plc (LSE: CREI) announces purchase of ordinary shares by Independent Non-Executive Directors. Details of the transactions and the Directors' interests in ordinary shares disclosed as required by Market Abuse Regulations -
PRESS RELEASE
Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Theralase® Technologies Inc. announces the addition of Dr. Michael Jewett as an independent consultant to assist in completing enrollment of patients in the Phase II NMIBC CIS clinical study. Dr. Jewett's expertise will help achieve regulatory approval
